WWW.EXFILE.COM, INC. -- 888-775-4789 -- BOSTON SCIENTIFIC CORPORATION -- FORM 8K
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): April 15, 2009
BOSTON SCIENTIFIC
CORPORATION
(Exact
name of registrant as specified in charter)
DELAWARE
|
1-11083
|
04-2695240
|
(State or other
jurisdiction of incorporation)
|
(Commission file
number)
|
(IRS
employer identification no.)
|
One Boston
Scientific Place, Natick, Massachusetts
|
01760-1537 |
(Address of
principal executive offices)
|
(Zip
code)
|
Registrant’s
telephone number, including area code: (508) 650-8000
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the fling obligation of the registrant under any of the following
provisions:
[
] Written communication pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[
] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[
] Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
[
] Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
ITEM
2.02. RESULTS OF OPERATIONS AND FINANCIAL
CONDITION.
On April
15, 2009, we announced special items that will reduce our GAAP earnings for the
first quarter of 2009. We plan to release our first quarter financial
results on April 20, 2009.
A copy of
the April 15, 2009 press release is filed as Exhibit 99.1.
ITEM
9.01. FINANCIAL STATEMENTS AND EXHIBITS.
Exhibit No. Description
99.1
|
Press
release issued by Boston Scientific Corporation dated April 15,
2009
|
SIGNATURE
Pursuant to the
requirements of the Securities and Exchange Act of 1934, as amended, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BOSTON SCIENTIFIC
CORPORATION
|
Company
Name |
|
|
|
|
|
Date:
April 15, 2009
|
By:
|
/s/ Lawrence
J. Knopf |
|
|
|
Lawrence
J. Knopf |
|
|
|
Senior
Vice President and Deputy General Counsel |
|
|
|
|
|
EXHIBIT
INDEX
Exhibit No. Description
99.1 Press
Release issued by Boston Scientific Corporation dated April 15,
2009